The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kasimova L.N.

Privolzhsky Research Medical University

Svyatogor M.V.

Privolzhsky Research Medical University

Angedonia in the structure of affective disorders: therapeutic opportunities

Authors:

Kasimova L.N., Svyatogor M.V.

More about the authors

Read: 34887 times


To cite this article:

Kasimova LN, Svyatogor MV. Angedonia in the structure of affective disorders: therapeutic opportunities. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(11):116‑122. (In Russ.)
https://doi.org/10.17116/jnevro2019119111116

Recommended articles:
Targeting NMDAR/AMPAR: a promising pharmacotherapeutic approach for depressive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):22-30
Asthenia in young patients and possibilities for its correction. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):133-137
Sleep diso­rders and onco­logical diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5-2):125-131
Reco­gnan (citicoline) in the correction of asthenic and anxiety-depressive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):43-47
Fluvoxamine in the treatment of anxiety-depressive spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):101-109
Anti­depressants in psychiatric practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):126-132
Sero­tonin syndrome: focus on opioid analgesics. Russian Journal of Pain. 2024;(3):98-106

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.